An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma
Clinical trial NCT00544440 · COMPLETED
Trial details
- NCT number
- NCT00544440
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2012-08-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.